Health · Medical Research · 5 hrs ago

Study links rare gut complication after CAR T therapy to persistent cells

Study links rare gut complication after CAR T therapy to persistent cells

Researchers studied a rare gut complication after CAR T treatment in people with multiple myeloma, a blood cancer.

The condition, called IEC-EC, can cause lasting diarrhea and inflammation, and may lead to long hospital stays, intensive nutritional support and increased risk of death.

Among 158 patients given the CAR T treatment cilta-cel, nine developed IEC-EC, or about 5%.

Those patients had about 100 times more CAR T cells persisting in their blood than patients who did not develop the condition.

Tests of tissue samples found CAR T cells in the digestive tract, where they appeared to drive ongoing inflammation and damage.

The findings suggest that monitoring CAR T cells may help flag risk earlier, while examining the upper small intestine and testing tissue for CAR T cells could help diagnose the condition.

More studies are needed to identify who is most at risk and how to prevent the complication.

1 source

Related

What people are saying

Mark HamiltonStudy corresponding author and assistant professor of Lymphoma & Myeloma
Our study found that IEC-EC is not just inflammation of the gastrointestinal tract, but it is a distinct CAR T cell therapy-driven immune cell disorder.
via News-Medical